These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 29985265)
21. HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy. Pillay V; Pillay C; Kantor R; Venter F; Levin L; Morris L AIDS Res Hum Retroviruses; 2008 Nov; 24(11):1449-54. PubMed ID: 19000027 [TBL] [Abstract][Full Text] [Related]
22. One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India. Gupta A; Saple DG; Nadkarni G; Shah B; Vaidya S; Hingankar N; Chaturbhuj D; Deshmukh P; Walshe L; Hudelson SE; James M; Paranjape RS; Eshleman SH; Tripathy S AIDS Res Hum Retroviruses; 2010 Jan; 26(1):25-31. PubMed ID: 20063995 [TBL] [Abstract][Full Text] [Related]
23. HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study. Coetzee J; Hunt G; Jaffer M; Otwombe K; Scott L; Bongwe A; Ledwaba J; Molema S; Jewkes R; Gray GE PLoS One; 2017; 12(12):e0188606. PubMed ID: 29244809 [TBL] [Abstract][Full Text] [Related]
24. Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS). Palella FJ; Armon C; Buchacz K; Chmiel JS; Novak RM; D'Aquila RT; Brooks JT; J Antimicrob Chemother; 2014 Oct; 69(10):2826-34. PubMed ID: 24942257 [TBL] [Abstract][Full Text] [Related]
25. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa. Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607 [TBL] [Abstract][Full Text] [Related]
26. Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043). Fogel JM; Clarke W; Kulich M; Piwowar-Manning E; Breaud A; Olson MT; Marzinke MA; Laeyendecker O; Fiamma A; Donnell D; Mbwambo JK; Richter L; Gray G; Sweat M; Coates TJ; Eshleman SH; Chingono AH J Acquir Immune Defic Syndr; 2017 Feb; 74(2):158-165. PubMed ID: 27828875 [TBL] [Abstract][Full Text] [Related]
27. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya. Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281 [TBL] [Abstract][Full Text] [Related]
28. Primary resistance to antiretroviral drugs of HIV strains in Chad: a retrospective investigation by analysis of frozen dried blood spot samples. Keita A; Djimera N; Djarma O; N'Guyen Y; Bourlet T; Andreoletti L Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):1091-1095. PubMed ID: 33237460 [TBL] [Abstract][Full Text] [Related]
29. HIV transmission dynamics and population-wide drug resistance in rural South Africa. Kemp SA; Kamelian K; Cuadros DF; ; ; Cheng MTK; Okango E; Hanekom W; Ndung'u T; Pillay D; Bonsall D; Wong EB; Tanser F; Siedner MJ; Gupta RK Nat Commun; 2024 Apr; 15(1):3644. PubMed ID: 38684655 [TBL] [Abstract][Full Text] [Related]
30. Antiretroviral resistance in HIV-infected Saudi children failing first-line highly active antiretroviral therapy. Al Hajjar SH; Frayha H; Althawadi S Ann Saudi Med; 2012; 32(6):565-9. PubMed ID: 23396017 [TBL] [Abstract][Full Text] [Related]
31. The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial. Pettifor A; MacPhail C; Hughes JP; Selin A; Wang J; Gómez-Olivé FX; Eshleman SH; Wagner RG; Mabuza W; Khoza N; Suchindran C; Mokoena I; Twine R; Andrew P; Townley E; Laeyendecker O; Agyei Y; Tollman S; Kahn K Lancet Glob Health; 2016 Dec; 4(12):e978-e988. PubMed ID: 27815148 [TBL] [Abstract][Full Text] [Related]
32. Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa. Gottlieb GS; Badiane NM; Hawes SE; Fortes L; Toure M; Ndour CT; Starling AK; Traore F; Sall F; Wong KG; Cherne SL; Anderson DJ; Dye SA; Smith RA; Mullins JI; Kiviat NB; Sow PS; Clin Infect Dis; 2009 Feb; 48(4):476-83. PubMed ID: 19143530 [TBL] [Abstract][Full Text] [Related]
33. Drug resistance profiles among HIV-1-infected children experiencing delayed switch and 12-month efficacy after using second-line antiretroviral therapy: an observational cohort study in rural China. Zhao Y; Mu W; Harwell J; Zhou H; Sun X; Cheng Y; Li C; Zhang F J Acquir Immune Defic Syndr; 2011 Sep; 58(1):47-53. PubMed ID: 21725248 [TBL] [Abstract][Full Text] [Related]
34. Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South Africa. Hoffmann CJ; Cohn S; Mashabela F; Hoffmann JD; McIlleron H; Denti P; Haas DW; Dooley KE; Martinson NA; Chaisson RE J Acquir Immune Defic Syndr; 2016 Jan; 71(1):31-7. PubMed ID: 26334739 [TBL] [Abstract][Full Text] [Related]
35. Human Immunodeficiency Virus (HIV) Drug Resistance, Phylogenetic Analysis, and Superinfection Among Men Who Have Sex with Men and Transgender Women in Sub-Saharan Africa: HIV Prevention Trials Network (HPTN) 075 Study. Sivay MV; Palumbo PJ; Zhang Y; Cummings V; Guo X; Hamilton EL; McKinstry L; Ogendo A; Kayange N; Panchia R; Dominguez K; Chen YQ; Sandfort TGM; Eshleman SH Clin Infect Dis; 2021 Jul; 73(1):60-67. PubMed ID: 32761071 [TBL] [Abstract][Full Text] [Related]
36. Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma. Soulie C; Descamps D; Grudé M; Schneider V; Trabaud MA; Morand-Joubert L; Delaugerre C; Montes B; Barin F; Ferre V; Raymond S; Jeulin H; Alloui C; Yerly S; Pallier C; Reigadas S; Signori-Schmuck A; Guigon A; Fafi-Kremer S; Haïm-Boukobza S; Mirand A; Maillard A; Vallet S; Roussel C; Assoumou L; Calvez V; Flandre P; Marcelin AG; J Antimicrob Chemother; 2015 Feb; 70(2):566-72. PubMed ID: 25344810 [TBL] [Abstract][Full Text] [Related]
37. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy. Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968 [TBL] [Abstract][Full Text] [Related]
38. Pretreatment HIV Drug Resistance and Virologic Outcomes to First-Line Antiretroviral Therapy in Peru. Soria J; Mugruza R; Levine M; León SR; Arévalo J; Ticona E; Beck IA; Frenkel LM AIDS Res Hum Retroviruses; 2019 Feb; 35(2):150-154. PubMed ID: 30560685 [TBL] [Abstract][Full Text] [Related]
39. Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens. Van Zyl GU; Liu TF; Claassen M; Engelbrecht S; de Oliveira T; Preiser W; Wood NT; Travers S; Shafer RW PLoS One; 2013; 8(6):e67188. PubMed ID: 23840622 [TBL] [Abstract][Full Text] [Related]
40. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis. Zeh C; Weidle PJ; Nafisa L; Lwamba HM; Okonji J; Anyango E; Bondo P; Masaba R; Fowler MG; Nkengasong JN; Thigpen MC; Thomas T PLoS Med; 2011 Mar; 8(3):e1000430. PubMed ID: 21468304 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]